UY26266A1 - ANTIGEN ASSOCIATED WITH TUMORS (R11) LAW 17164 - Google Patents

ANTIGEN ASSOCIATED WITH TUMORS (R11) LAW 17164

Info

Publication number
UY26266A1
UY26266A1 UY26266A UY26266A UY26266A1 UY 26266 A1 UY26266 A1 UY 26266A1 UY 26266 A UY26266 A UY 26266A UY 26266 A UY26266 A UY 26266A UY 26266 A1 UY26266 A1 UY 26266A1
Authority
UY
Uruguay
Prior art keywords
tumors
law
antigen associated
immunotherapy
encode
Prior art date
Application number
UY26266A
Other languages
Spanish (es)
Inventor
Konopitzky Renate Koen Woelfel
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of UY26266A1 publication Critical patent/UY26266A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Antígenos asociados con tumores, pépticos inmunógenos derivados de ellos y moleculares de ADN que codifican a éstos, así como su utilización en la inmunoterapia de enfermedades de cáncer.Antigens associated with tumors, immunogenic peptides derived from them and molecular DNA that encode them, as well as their use in the immunotherapy of cancer diseases.

UY26266A 1999-08-04 2000-08-02 ANTIGEN ASSOCIATED WITH TUMORS (R11) LAW 17164 UY26266A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19936563A DE19936563A1 (en) 1999-08-04 1999-08-04 Tumor Associated Antigen

Publications (1)

Publication Number Publication Date
UY26266A1 true UY26266A1 (en) 2001-01-31

Family

ID=7917065

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26266A UY26266A1 (en) 1999-08-04 2000-08-02 ANTIGEN ASSOCIATED WITH TUMORS (R11) LAW 17164

Country Status (9)

Country Link
EP (1) EP1206535A1 (en)
JP (1) JP2003506085A (en)
AU (1) AU6278300A (en)
CA (1) CA2383230A1 (en)
CO (1) CO5280153A1 (en)
DE (1) DE19936563A1 (en)
MX (1) MXPA02001137A (en)
UY (1) UY26266A1 (en)
WO (1) WO2001011040A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8258260B2 (en) 1970-02-11 2012-09-04 Immatics Biotechnologies Gmbh Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
US8211999B2 (en) 1970-02-11 2012-07-03 Immatics Biotechnologies Gmbh Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
US8212000B2 (en) 1970-02-11 2012-07-03 Immatics Biotechnologies Gmbh Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
JP2003093066A (en) * 2001-09-21 2003-04-02 Univ Tokyo Method for controlling proliferation and apoptosis of carcinoma cell
CA2469738A1 (en) 2001-11-07 2003-08-07 Mannkind Corporation Expression vectors encoding epitopes of target-associated antigens and methods for their design
DE10211088A1 (en) * 2002-03-13 2003-09-25 Ugur Sahin Gene products differentially expressed in tumors and their use
US20050221350A1 (en) 2002-05-29 2005-10-06 Toni Weinschenk Method for identifying immunoreactive peptides
DE10225144A1 (en) 2002-05-29 2003-12-18 Immatics Biotechnologies Gmbh Tumor-associated peptides binding to MHC molecules
DE10341812A1 (en) * 2003-09-10 2005-04-07 Ganymed Pharmaceuticals Ag Differentially expressed in tumors gene products and their use
DE102005041616B4 (en) * 2005-09-01 2011-03-17 Johannes-Gutenberg-Universität Mainz Melanoma associated MHC class I associated oligopeptides and polynucleotides encoding them and their uses
ES2341802T3 (en) 2005-09-05 2010-06-28 Immatics Biotechnologies Gmbh PEPTIDES ASSOCIATED WITH UNITED TUMORS PROMISCUALLY TO MOLECULES OF THE HUMAN LEUKOCYTE ANTIGEN (HLA) CLASS II.
DK2364366T3 (en) 2008-11-05 2014-03-31 Morphosys Ag Folding method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999018206A2 (en) * 1997-10-08 1999-04-15 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Human cancer antigen ny eso-1/cag-3 and gene encoding same
WO2000058473A2 (en) * 1999-03-31 2000-10-05 Curagen Corporation Nucleic acids including open reading frames encoding polypeptides; 'orfx'

Also Published As

Publication number Publication date
DE19936563A1 (en) 2001-02-08
CA2383230A1 (en) 2001-02-15
AU6278300A (en) 2001-03-05
JP2003506085A (en) 2003-02-18
CO5280153A1 (en) 2003-05-30
MXPA02001137A (en) 2002-11-04
EP1206535A1 (en) 2002-05-22
WO2001011040A1 (en) 2001-02-15

Similar Documents

Publication Publication Date Title
CY1118443T1 (en) ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USES
CY1119291T1 (en) LITTLE ANTIBODIES AND USES FOR THEM
NZ335485A (en) Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
CY1108960T1 (en) CRIPTO EXCLUSION COTTAGES AND THEIR USES
TR200001646T2 (en) Mamaglobin, a secreted breast cancer protein.
CY1107628T1 (en) HUMAN CTLA-4 ANTIBODIES AND USES
MXPA03000527A (en) Compositions and methods for the therapy and diagnosis of ovarian cancer.
ATE403680T1 (en) PRODUCTION OF TETRAVALENT ANTIBODIES
DE69934426D1 (en) Cancer Immune Therapy and Cancer Diagnosis Using Universal Tumeric Assays
CY1112993T1 (en) SPECIFIC COMMITMENT FACTORS OF VASCULAR-2 AND VASCULAR-1
ATE209680T1 (en) ISOLATED NUCLEIC ACID MOLECULES, PEPTIDES THAT FORM COMPLEXES WITH HLA-A2 MOLECULES (MHC), AND THEIR USES
TR200002731T2 (en) Methods for the identification, composition and use of inductors and inhibitors of proteolytic antibodies
IL163902A0 (en) Antibodies against cancer antigen tmeff2 and uses thereof
UY26266A1 (en) ANTIGEN ASSOCIATED WITH TUMORS (R11) LAW 17164
AU8727201A (en) Genes involved in intestinal inflammatory diseases and use thereof
DE60315827D1 (en) IMPROVED POLYSACCHARIDE AND GLYCOCONJUGATE VACCINE
DE60238555D1 (en) PARATHORMONE ANTIBODIES AND ASSOCIATED METHODS
EP1230932A3 (en) Use of antibodies for anticancer vaccination
UY26170A1 (en) ANTIGEN (C42) ASSOCIATED WITH TUMORS
ZA971403B (en) Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof.
CY1106200T1 (en) ANTIBODIES TO CASPASE-8, THEIR PREPARATION AND USE
AR023794A1 (en) ANTIGEN ASSOCIATED WITH TUMORS
BRPI0409321A (en) antigen hybrid, competition and method for inducing an immune response to an infectious agent or tumor antigen, method for treating an infectious disease or cancer, and, peptide
UY26127A1 (en) ANTIGEN ASSOCIATED WITH TUMORS
ATE209041T1 (en) TUMOR REJECTION ANTIGENS PRESENTED BY HLA-B44 MOLECULES AND THEIR USE

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20100830